Jane Street
GALT icon

Jane Street’s Galectin Therapeutics GALT Stock Holding History

Jane Street’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-194,868
Closed -$505K – 12099
2026
Q1 		$544K Sell
194,868
-4,471
-2% -$13.6K ﹤0.01% 7848
2025
Q4 		$829K Buy
199,339
+184,663
+1,258% +$972K ﹤0.01% 6538
2025
Q3 		$62.2K Sell
14,676
-733,976
-98% -$2.76M ﹤0.01% 10288
2025
Q2 		$1.58M Buy
+748,652
New +$1.12M ﹤0.01% 4807
2024
Q2 		– Sell
-36,785
Closed -$87.9K – 9664
2024
Q1 		$87.9K Buy
36,785
+3,016
+9% +$5.71K ﹤0.01% 8572
2023
Q4 		$56.1K Buy
+33,769
New +$65.5K ﹤0.01% 8757
2023
Q2 		– Sell
-40,522
Closed -$85.1K – 8974
2023
Q1 		$85.1K Buy
40,522
+5,124
+14% +$8.27K ﹤0.01% 8296
2022
Q4 		$40K Buy
+35,398
New +$47.2K ﹤0.01% 8437
2021
Q3 		– Sell
-11,133
Closed -$37.7K – 10202
2021
Q2 		$36K Buy
+11,133
New +$39.6K ﹤0.01% 9564
2019
Q4 		– Sell
-23,849
Closed -$88K – 5293
2019
Q3 		$88K Buy
+23,849
New +$86.2K ﹤0.01% 4812
2019
Q2 		– Sell
-22,029
Closed -$113K – 5338
2019
Q1 		$113K Buy
+22,029
New +$106K ﹤0.01% 4758
2018
Q3 		– Sell
-14,369
Closed -$91K – 5310
2018
Q2 		$91K Buy
+14,369
New +$70K ﹤0.01% 4750
2014
Q3 		– Sell
-19,096
Closed -$264K – 2727
2014
Q2 		$264K Buy
19,096
+5,745
+43% +$71.5K ﹤0.01% 1943
2014
Q1 		$204K Buy
+13,351
New +$190K ﹤0.01% 2351
2013
Q4 		– Sell
-10,076
Closed -$100K – 2540
2013
Q3 		$100K Buy
+10,076
New +$68K ﹤0.01% 2547

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street's GALT Position: Q2 2026 in Review

Jane Street sold out of Galectin Therapeutics (GALT) in Q2 2026, closing a stake of 194,868 shares — an estimated $505K sold.

Jane Street first reported a position in GALT in Q3 2013 and held it in 15 quarters. The position peaked at $1.58M in Q2 2025. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • Jane Street reported no remaining Galectin Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 194,868 Galectin Therapeutics shares in Q2 2026, an estimated $505K.
  • Jane Street first reported a position in Galectin Therapeutics in Q3 2013 and held it in 15 quarters.
  • Jane Street's Galectin Therapeutics position peaked at $1.58M in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.